Anileridine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s. It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.

Anileridine is no longer manufactured in the US or Canada.^[1]

Administration

As tablets or injection.^[2]

Pharmacokinetics

Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.^[3] It is mostly metabolized by the liver.

References

↑ “Discontinued Prescription Drug Products”. Canadian Pharmacists’ Association. Retrieved 28 July 2008.
↑ “Pharmaceutical Information – LERITINE”. RxMed. Retrieved 16 June 2010.
↑ “Anileridine Consumer Information”. MedicineNet. Retrieved 28 July 2008.

Template:General anesthetics

[1] “Discontinued Prescription Drug Products”. Canadian Pharmacists’ Association. Retrieved 28 July 2008.

[2] “Pharmaceutical Information – LERITINE”. RxMed. Retrieved 16 June 2010.

[3] “Anileridine Consumer Information”. MedicineNet. Retrieved 28 July 2008.

[1]

[2]

[3]